Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $148.97 USD
Change Today -0.67 / -0.45%
Volume 80.0K
BIO On Other Exchanges
New York
New York
As of 8:04 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

bio-rad laboratories-a (BIO) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/15/15 - $152.38
52 Week Low
11/5/14 - $102.71
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIO-RAD LABORATORIES-A (BIO)

Related News

No related news articles were found.

bio-rad laboratories-a (BIO) Related Businessweek News

View More BusinessWeek News

bio-rad laboratories-a (BIO) Details

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software, which address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network. It has operations in Europe, Pacific Rim, the United States, and internationally. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

7,600 Employees
Last Reported Date: 03/2/15
Founded in 1952

bio-rad laboratories-a (BIO) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $843.1K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $423.3K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $609.0K
Executive Vice President and President of Cli...
Total Annual Compensation: $432.6K
Chief Strategy Officer and Executive Vice Pre...
Total Annual Compensation: $425.7K
Compensation as of Fiscal Year 2014.

bio-rad laboratories-a (BIO) Key Developments

Bio-Rad Laboratories, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides CapEx Guidance for the Full Year 2015

Bio-Rad Laboratories, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenues of $472.8 million, down 7.2% compared to $509.3 million reported for the first quarter of 2014. On a currency-neutral basis, quarterly revenues increased 1.4% compared to the same period last year. Net income was $17.8 million, or $0.61 per share on a fully diluted basis compared to $6.7 million or $0.23 per share during the same period last year. Income from operations was $34,349,000 compared to $20,471,000 a year ago. Income before income taxes was $26,694,000 compared to $14,538,000 a year ago. Net cash generated from operations during the quarter was just over $29 million compared to $40 million last quarter and $66 million in the year-ago period. This decrease in cash flow versus last year is primarily the result of lower customer collections resulting from the decrease in reported sales, which includes more than $30 million of currency headwinds and receivables as well as increased employee-related payments associated with various 2014 incentive plans. Net capital expenditures for the quarter were slightly lower than expected at $27 million. For the full year 2015, the company's expectation for CapEx remains in the $130 million to $140 million range as it continue to invest in its global ERP system. The company continue to expect the full year effective tax rate to be in the 33% to 35% range.

Bio-Rad Laboratories, Inc. to Report Q1, 2015 Results on May 05, 2015

Bio-Rad Laboratories, Inc. announced that they will report Q1, 2015 results at 2:00 PM, Pacific Standard Time on May 05, 2015

Bio-Rad Laboratories, Inc., Q1 2015 Earnings Call, May 05, 2015

Bio-Rad Laboratories, Inc., Q1 2015 Earnings Call, May 05, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIO:US $148.97 USD -0.67

BIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $52.68 USD +2.59
BioMerieux €107.75 EUR +0.05
DiaSorin SpA €43.54 EUR +0.04
IDEXX Laboratories Inc $73.45 USD -0.72
QIAGEN NV €25.91 EUR +0.005
View Industry Companies

Industry Analysis


Industry Average

Valuation BIO Industry Range
Price/Earnings 43.7x
Price/Sales 2.0x
Price/Book 2.0x
Price/Cash Flow 35.9x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-RAD LABORATORIES-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at